Argus Research Raises Tesla TSLA PT to $1,313 from $1,010, as Company Is 'undisputed leader' in Industry

Eva Fox by Eva Fox December 29, 2021

Argus Research Raises Tesla TSLA PT to $1,313 from $1,010, as Company Is 'undisputed leader' in Industry

Argus Research raised its price target for Tesla (NASDAQ: TSLAshares on Tuesday, boosting it to $1,313 from $1,010 and reaffirming its buy rating. The firm considers the company the "undisputed leader" in the industry, even in the face of "growing competition."

Following Wedbush, Argus Research is also showing a confident optimism and outlook on Tesla stock. The firm has raised its price target to $1,313 from $1,010 as it believes Tesla is a clear leader in the increasingly competitive electric vehicle market.

"Our revised target price of $1,313 implies a return of approximately 30% from current prices," Argus says in a note. "We are raising our 2021 EPS estimate to $6.16 from $5.67 to reflect our modestly higher revenue and Automotive segment gross margin assumptions." "We are also raising our 2022 EPS estimate to $8.66 from $7.68, implying 41% growth from our 2021 estimate," the firm continued.

© 2021, Eva Fox | Tesmanian. All rights reserved.

_____________________________

We appreciate your readership! Please share your thoughts in the comment section below.

Legal Disclaimer --

This article is for informational purposes only. You should not construe any such information or other material as an investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by Eva Fox, Tesmanian, or any third party service provider to buy or sell any securities or other financial instruments in this or in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction.

Eva Fox holds zero shares of Tesla, Inc., and currently (at the time of this article's publishing) holds zero options or securities in Tesla Inc. and/or its affiliates.





Previous  / Next